leisure time -WSS

leisure time

author：focus 2025-10-06 10:32:45 - browse：67

After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： The pain doctors face in trying to build their families

explore

WSS

Eye stem cell transplant could help restore vision in injured people

Data integrity in scientific journals requires "effort" by publishers, institutions

ActiGraph execs on goal of drug approvals with digital endpoints

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Beware the threat of staffing cuts at the CDC

Ukraine taking heavy casualties 10 weeks into its counteroffensive

focus

leisure time

hotspot

Supreme Court strikes down use of affirmative action

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

BioMarin wins approval for gene therapy to treat hemophilia A

Listen: Racing for gene therapy & a pioneering approval

How one medical school became remarkably diverse

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Psychedelics group wrestles with new pharma identity

ProMED sees offers of support, but its future remains unclear

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Solving academic medical centers' existential crisis

hotspot

Cytokinetics CEO stresses company can launch heart drug on its own

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

HIV vaccine remains elusive. Immunologists keep trying new ideas

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Beware the threat of staffing cuts at the CDC

Data integrity in scientific journals requires "effort" by publishers, institutions

explore

explore

focus

hotspot